Keywords: فعال عامل X; OAC; Oral anticoagulant; VKA; Vitamin K antagonist; DOAC; Direct oral anticoagulant; PCC; Prothrombin complex concentrate; 4F-PCC; Four factor PCC; 3F-PCC; Three factor PCC; aPCC; Activated PCC; FFP; Fresh frozen plasma; AF; Atrial fibrillation; TE; Throm
مقالات ISI فعال عامل X (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: فعال عامل X; AF; atrial fibrillation; INR; international normalized ratio; factor Xa; activated factor X; DOACs; direct-acting oral anticoagulants; RCTs; randomized controlled trials; RE-LY; Dabigatran Randomized Evaluation of Long-Term Anticoagulant Therapy; ROCKET-A
Keywords: فعال عامل X; fVII; factor VII; fVIIa; activated factor VII; fXa; activated factor X; HNSCC; head and neck squamous cell carcinoma; LMWH; low molecular weight heparin; MM; multiple myeloma; MP; microparticles; PCA; procoagulant activity; PE; phosphatidylethanolamine; P
Inhibition of activated factor X by rivaroxaban attenuates neointima formation after wire-mediated vascular injury
Keywords: فعال عامل X; Macrophage; Neointima formation; Inflammation; Activated factor X; Rivaroxaban;
Pro- and anti-inflammatory effects of histamine on tissue factor and TNFα expression in monocytes of human blood
Keywords: فعال عامل X; ASA; acetylsalicylic acid; FV; Factor V; FVIIa; activated Factor VII; FXa; activated Factor X; LPS; lipopolysaccharide; TF; tissue factor; PMA; phorbol myristate acetate; PKC; protein kinase C; PKD; protein kinase D; PSGL-1; P-selectin glycoprotein-1; TNF
Regular ArticleInhibitory effects of LDL-associated tissue factor pathway inhibitor
Keywords: فعال عامل X; BSA; bovine serum albumin; CAT; calibrated automated thrombogram; dPT; diluted prothrombin time; FVIIa; activated factor VII; FX; factor X; FXa; activated factor X; GPI; glycosyl phosphatidyl inositol; HBS; hepes buffered saline; IP; immuno pull down; KI;
Treatment of venous thrombosis with an oral direct factor Xa inhibitor edoxaban by single and multiple administrations in rats
Keywords: فعال عامل X; APTT; activated partial thromboplastin time; BID; twice daily; DVT; deep vein thrombosis; factor Xa; activated factor X; HE; hematoxylin and eosin; PE; pulmonary embolism; PT; prothrombin time; PTAH; phosphotungstic acid hematoxylin; QD; once daily; S.E.M
Characterization of the protein Z-dependent protease inhibitor interactive-sites of protein Z
Keywords: فعال عامل X; PZ; protein Z; ZPI; protein Z-dependent protease inhibitor; RCL; reactive center loop; ZPI-Y387A; a ZPI mutant in which Tyr-387 has been replaced with an Ala; FXa; activated factor X; Gla; γ-carboxyglutamic acid; EGF; epidermal growth factor; PZ/FX-LC; a
Assembly of the prothrombinase complex on the surface of human foreskin fibroblasts: Implications for connective tissue growth factor
Keywords: فعال عامل X; FXa; activated factor X; CTGF/CCN2; connective tissue growth factor; TF; tissue factor; TSP1; thrombospondin-1; HFF; human foreskin fibroblasts; FVII; factor VII; FX; factor X; FV; factor V; II; prothrombin; TGFβ; transforming growth factor beta; TGFβRI
Antioxidant and antiatherogenic activities of pentacyclic triterpenic diols and acids
Keywords: فعال عامل X; AAPH; 2,2'-azobis (2-methylpropionamidine) dihydrochloride; BHT; butylated hydroxytoluene; BSA; bovine serum albumin; DMSO; dimetyhl sulfoxide; EDTA; ethylenediaminetetraacetic acid; FL; fluorescein; FV; coagulation factor V; FXa; activated factor X; LD
Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor
Keywords: فعال عامل X; FVIIa; activated factor VII; FX; factor X; FXa; activated factor X; Gla; γ-carboxyglutamic acid; PDI; protein disulfide isomerase; sTF; soluble tissue factor; TF; tissue factor; Factor X activation; Protein disulfide isomerise; Factor VIIa; Tissue factor
Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis
Keywords: فعال عامل X; PZ; protein Z; anti-PZ; anti-protein Z; ZPI; protein Z-dependent protease inhibitor; Xa; activated factor X; OD; optical density; AU; arbitrary unit; PBS; phosphate buffered saline; NCEP-III; National Cholesterol Education Program; ANOVA; analysis of vari
Differences in circadian variations of tissue factor pathway inhibitor type 1 between able-bodied and spinal cord injured
Keywords: فعال عامل X; TFPI; Tissue factor pathway inhibitor; FXa; Activated factor X; LDL; Low density lipoprotein; HDL; High density lipoprotein; VLDL; Very low density lipoprotein; TG; Triglycerides; OC; Oral contraceptives; HRT; Hormone replacement therapy; PAI-1; Plasminog
Thromsbospondin-1 binds to the heavy chain of elastase activated coagulation factor V (FVaHNE) and enhances thrombin generation on the surface of a promyelocytic cell line
Keywords: فعال عامل X; TSP1; thrombospondin-1; HNE; human neutrophil elastase; HBSS; Hanks Balanced Salt Solution; RT-PCR; reverse trasnscriptase polymerase chain reaction; APL; acute promyelocytic leukemia; HBD; heparin binding site; TFPI; tissue factor pathway inhibitor; FXa;